ellipticine has been researched along with Disease Models, Animal in 7 studies
ellipticine : A organic heterotetracyclic compound that is pyrido[4,3-b]carbazole carrying two methyl substituents at positions 5 and 11.
Disease Models, Animal: Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Ellipticine treatment dramatically reduced inflammatory cells infiltration, MPO activity, serum amylase and lipase activity and the protein concentration of BALF." | 5.56 | Ellipticine blocks synergistic effects of IL-17A and TNF-α in epithelial cells and alleviates severe acute pancreatitis-associated acute lung injury. ( Li, X; Mulati, M; Qian, F; Sun, L; Ye, C, 2020) |
| "Although inflammation has been clearly identified as a key factor in the onset and progression of cancer, the relationship between ellipticine and inflammation remains unknown." | 1.56 | Ellipticine Conveys Protective Effects to Lipopolysaccharide-Activated Macrophages by Targeting the JNK/AP-1 Signaling Pathway. ( Li, XY; Liang, HP; Luo, L; Ma, W; Ma, XY; Tang, WQ; Tang, X; Tian, LX; Xu, X; Yan, J; Yang, X; Yu, J; Zhou, XY, 2020) |
| "Ellipticine treatment dramatically reduced inflammatory cells infiltration, MPO activity, serum amylase and lipase activity and the protein concentration of BALF." | 1.56 | Ellipticine blocks synergistic effects of IL-17A and TNF-α in epithelial cells and alleviates severe acute pancreatitis-associated acute lung injury. ( Li, X; Mulati, M; Qian, F; Sun, L; Ye, C, 2020) |
| "Ellipticine has been shown previously to exhibit excellent in vitro antiplasmodial activity and in vivo antimalarial properties that are comparable to those of the control drug chloroquine in a mouse malaria model." | 1.40 | Antiplasmodial activity of synthetic ellipticine derivatives and an isolated analog. ( Amorim, RC; Costa, DS; Costa, MR; Eberlin, MN; Grafov, A; Grafova, I; Henrique, MC; Lima, ES; Montoia, A; Pohlit, AM; Rocha E Silva, LF; Souza, RC; Tadei, WP; Torres, ZE; Vasconcellos, MC, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 4 (57.14) | 2.80 |
| Authors | Studies |
|---|---|
| Hong, JY | 1 |
| Chung, HJ | 1 |
| Lee, HJ | 1 |
| Park, HJ | 1 |
| Lee, SK | 1 |
| Montoia, A | 1 |
| Rocha E Silva, LF | 1 |
| Torres, ZE | 1 |
| Costa, DS | 1 |
| Henrique, MC | 1 |
| Lima, ES | 1 |
| Vasconcellos, MC | 1 |
| Souza, RC | 1 |
| Costa, MR | 1 |
| Grafov, A | 1 |
| Grafova, I | 1 |
| Eberlin, MN | 1 |
| Tadei, WP | 1 |
| Amorim, RC | 1 |
| Pohlit, AM | 1 |
| Solinski, HJ | 1 |
| Dranchak, P | 1 |
| Oliphant, E | 1 |
| Gu, X | 1 |
| Earnest, TW | 1 |
| Braisted, J | 1 |
| Inglese, J | 1 |
| Hoon, MA | 1 |
| Abrams, RPM | 1 |
| Yasgar, A | 1 |
| Teramoto, T | 1 |
| Lee, MH | 1 |
| Dorjsuren, D | 1 |
| Eastman, RT | 1 |
| Malik, N | 1 |
| Zakharov, AV | 1 |
| Li, W | 1 |
| Bachani, M | 1 |
| Brimacombe, K | 1 |
| Steiner, JP | 1 |
| Hall, MD | 1 |
| Balasubramanian, A | 1 |
| Jadhav, A | 1 |
| Padmanabhan, R | 1 |
| Simeonov, A | 1 |
| Nath, A | 1 |
| Tian, LX | 1 |
| Li, XY | 1 |
| Tang, X | 1 |
| Zhou, XY | 1 |
| Luo, L | 1 |
| Ma, XY | 1 |
| Tang, WQ | 1 |
| Yu, J | 1 |
| Ma, W | 1 |
| Yang, X | 1 |
| Yan, J | 1 |
| Xu, X | 1 |
| Liang, HP | 1 |
| Li, X | 2 |
| Ye, C | 1 |
| Mulati, M | 1 |
| Sun, L | 1 |
| Qian, F | 1 |
| Wang, C | 1 |
| Lu, H | 1 |
| Liu, M | 1 |
| Wang, G | 1 |
| Lu, W | 1 |
| Dong, W | 1 |
| Wang, X | 1 |
| Chen, H | 1 |
| Tan, C | 1 |
7 other studies available for ellipticine and Disease Models, Animal
| Article | Year |
|---|---|
Growth inhibition of human lung cancer cells via down-regulation of epidermal growth factor receptor signaling by yuanhuadine, a daphnane diterpene from Daphne genkwa.
Topics: Animals; Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Cell Cycle; Daphne; Dise | 2011 |
Antiplasmodial activity of synthetic ellipticine derivatives and an isolated analog.
Topics: Animals; Antimalarials; Aspidosperma; Chloroquine; Disease Models, Animal; Ellipticines; Fibroblasts | 2014 |
Inhibition of natriuretic peptide receptor 1 reduces itch in mice.
Topics: Animals; Behavior, Animal; Cell-Free System; Dermatitis, Contact; Disease Models, Animal; Ganglia, S | 2019 |
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Dr | 2020 |
Ellipticine Conveys Protective Effects to Lipopolysaccharide-Activated Macrophages by Targeting the JNK/AP-1 Signaling Pathway.
Topics: Adult; Animals; Anti-Inflammatory Agents; Cell Proliferation; Disease Models, Animal; Ellipticines; | 2020 |
Ellipticine blocks synergistic effects of IL-17A and TNF-α in epithelial cells and alleviates severe acute pancreatitis-associated acute lung injury.
Topics: Acute Lung Injury; Adaptor Proteins, Signal Transducing; Amylases; Animals; Anti-Inflammatory Agents | 2020 |
Effective Antibacterial and Antihemolysin Activities of Ellipticine Hydrochloride against Streptococcus suis in a Mouse Model.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Cytokines; Disease Models, Animal; Ellipticines; | 2021 |